Abstract
Results of a new study offer evidence of an association between third‐generation antipsychotics (aripiprazole, brexpiprazole, and cariprazine) and impulse control disorders such as pathological gambling and compulsive shopping. The vast majority of the relevant reports identified in the study's examination of the Food and Drug Administration's (FDA's) Adverse Event Reporting System involved aripiprazole. Study results were published online May 27, 2022, in the International Journal of Neuropsychopharmacology.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
